The over-prescribing of opioids and subsequent problems of addiction, overdose, and even death is a public health crisis that has dramatically impacted workers’ compensation. A startling 55 to 85 percent of injured workers receive narcotics for chronic pain.
A recent study by Accident Fund Holdings and Johns Hopkins University examined the interrelationship between the utilization of short- and long-acting opioid medications and the likelihood of claim cost escalating to a catastrophic level (> $100,000). Analyzing 12,000 workers’ compensation claims in Michigan during a four-year period, the study focused on whether the presence of opioids alone accounted for the cost increase or whether costs increased because opioids were associated with known cost-drivers, such as legal involvement and injury severity.
Controlling for factors of sex, age, time lost from work, the number of distinct ICD-9 codes per claims and legal involvement, results showed that opioid use – particularly of long-acting (LA) opioids – was an independent predictor of catastrophic claims costs. Key findings:
- The presence of LA opioids makes claims almost 3.9 times more likely to have a final cost of >$100,000 than a claim without any prescriptions.
- Claims with only short acting (SA) opioids were 1.76 times more likely to have an ultimate claims cost of >$100,000.
- Claims with non-opioid prescriptions showed no significant risk of exceeding $100,000 int total claim cost.
When assessing the price of opioid medication as it related to total medical and overall claim cost, the study found that the price of the drug itself was a minor contributor to the overall medical or total claims cost. SA opioids represented 0.3 percent of the overall medical cost and 0.1 percent of overall claim cost, while LA opioids were approximately 3 percent of medical and 1.2 percent of total claim cost.
Strategies to Mitigate the Impact of Opioids
Tower MSA Partners: 223 NE 5th Avenue, Suite 101• Delray Beach, FL 33483
Telephone: 888.331.4941 • Fax: 888.331.4942 • E-mail: [email protected]
Copyright © 2015 Tower MSA Partners, LLC. All Rights Reserved